Medmira Shares Plunge 14% Amid Market Update – Current Price & Key Metrics
MedMira (MIR.V) slumps 14% as investors weigh biotech risks – see price, volume, 52‑week range and peers for quick market insights.
One minute to read
MEDMIRA INC.
Medmira Shares Surge 8.33% as Market Activity Boosts Investor Confidence
Medmira Inc. gains 8.33% as investors spot momentum in its low‑priced diagnostics stock, offering a potential buying opportunity amid a broader market correction.
2 minutes to read
Medmira (MIR.V) Holds Steady Amid Biotech Downturn, Awaiting Catalyst
Medmira (MIR.V) holds steady at CAD 0.06 amid a biotech slump—low liquidity, flat valuation, and a need for a breakthrough product or partnership to spark growth.
3 minutes to read